Report Presentation Webcast
August 24, 2023 Presentation - EPB Bolagsdag
August 24, 2023 Interim Report Q2 2023
May 25, 2023 Presentation Erik Penser Bank
May 25, 2023 Interim Report Q1 2023
April 25, 2023 Annual Report 2022
February 23, 2023 Year-end Report 2022
November 17, 2022 Interim Report January – September 2022
August 25, 2022 Interim Report January – June 2022
May 25, 2022 Interim Report January – March 2022
May 5, 2022 Anglonordic Life Science Conference
April 28, 2022 Annual Report 2021
March 14, 2022 Oasmia Pharmaceutical – Aktiedagen Stockholm
January 19, 2022 Year-end Report 2021
January 19, 2022 Rights Issue Presentation at Erik Penser Bank
December 2, 2021 Oasmia - Presentation Erik Penser Bank
December 2, 2021 Presentation at Stora Aktiedagen Stockholm
November 18, 2021 Interim Report January – September 2021
October 21, 2021 Interview Erik Penser Bank
September 29, 2021 Naventus LifeScience Summit
September 7, 2021 Presentation at Aktiedagen Stockholm
August 19, 2021 Interim Report January – June 2021
June 11, 2021 Aktiespararna: Interview with Oasmia Pharmaceutical
May 27, 2021 Interim Report January – March 2021
April 29, 2021 Annual Report 2020
April 12, 2021 Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting
March 21, 2021 BioEurope Spring, Virtual
March 11, 2021 Sachs 14th Annual European Life Sciences CEO Forum, Virtual
March 1, 2021 Oasmia acquires global development and commercialization rights for Cantrixil
February 19, 2021 Year-end report 2020
February 10, 2021 Swiss Nordic Bio
January 19, 2021 SEB Digital Healthcare Seminar Presentation
December 9, 2020 Interim Report May – October 2020 – Report
December 3, 2020 Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer
November 11, 2020 Investival Showcase 11-16 November 2020, Virtual Conference
29 October, 2020 BIO-Europe®, Virtual Conference
October 7, 2020 Oasmia Erik Penser Cancer Day Presentation
September 24, 2020 Oasmia Erik Penser Investor Event Presentation
September 21, 2020 Presentation at Sachs Biotech in Europe Forum
September 15, 2020 Aktiedagen Digitalt
September 9, 2020 Interim Report May – July 2020
August 19, 2020 Annual Report 2019 / 2020
July 30, 2020 Analysguiden: Interview with Oasmia
June 18, 2020 Year-end Report 2019 / 2020
June 10, 2020 Company Presentation Aktiespararna
June 3, 2020 Avanza Börsdag
May 13, 2020 Strategic Review Presentation
March 27, 2020 Interim Report May 2019 – January 2020
March 25, 2020 Elevar deal
February 14, 2020 Oasmia appoints new CEO
December 30, 2019 Interim Report May – October 2019
September 26, 2019 Interim Report May – July 2019
September 5, 2019 Annual Report 2018 / 2019
June 28, 2019 Year-end Report 2018 / 2019
March 1, 2019 Interim report May 2018 – January 2019
November 20, 2018 Interim report May – October 2018
August 31, 2018 Interim report May – July 2018
August 24, 2018 Annual Report 2017 / 2018
June 7, 2018 Year-end Report May 2017 – April 2018
March 2, 2018 Interim report May 2017 – January 2018
December 1, 2017 Interim report May – October 2017
October 31, 2017 US Interim report May – October 2016
September 1, 2017 Interim Report May – July 2017
August 24, 2017 Annual Report 2016 / 2017
August 2, 2017 Registration statement on form F3
June 8, 2017 Year-end Report May 2016 – April 2017
April 30, 2017 20-F Annual Report 2016-05-01 – 2017-04-30
March 2, 2017 Interim Report May 2016 – January 2017
December 1, 2016 US Interim report May – October 2016
December 1, 2016 Interim Report May – October 2016
September 1, 2016 Interim Report May 2016 – July 2016
August 25, 2016 Annual Report 2015 / 2016
July 29, 2016 Updated Registration Statement on Form F1
July 8, 2016 Updated Registration Statement on Form F1
July, 2016 US Interim Report May 2016 – July 2016
July 1, 2016 Registration statement and Prospectus on Form F1
June 2, 2016 Year-end Report May 2015 – April 2016
April 30, 2016 20-F Annual Report 2015-05-01 – 2016-04-30
April, 2016 US Year-end Report May 2015 – April 2016
March 2, 2016 Interim Report May 2015 – January 2016
January, 2016 US Interim Report May 2015 – January 2016
December 2, 2015 Interim Report May – October 2015
December 2, 2015 US Interim Report May – October 2015
October, 2015 US Interim Report May – October 2015
September 2, 2015 Interim Report May – July 2015
August 20, 2015 Annual Report 2014 / 2015
July 7, 2015 Updated Registration Statement and Prospectus on Form F1
June 3, 2015 Year-end Report May 2014 – April 2015
March 4, 2015 Interim Report May 2014 – January 2015
December 3, 2014 Interim Report May – October 2014
November, 2014 Prospectus new share issue November 2014
September 4, 2014 Interim Report May-July 2014
August 21, 2014 Annual Report 2013 / 2014
June 5, 2014 Year-end Report May 2013 – April 2014
March 6, 2014 Interim Report May 2013 – January 2014
December 5, 2013 Interim Report May – October 2013
September 6, 2013 Interim Report May – July 2013
August, 22 2013 Annual Report 2012 / 2013
June 7, 2013 Year-end Report May 2012 – April 2013
March 1, 2013 Interim Report May 2012 – January 2013
December 6, 2012 Interim Report May-October 2012
October 25, 2012 New share issue Prospectus 2012-10-25
September 6, 2012 Interim Report May-July 2012
August 23, 2012 Annual Report 2011 / 2012
June 14, 2012 Year-end Report May 2011-April 2012
March 8, 2012 Interim Report May 2011 – January 2012
December 8, 2011 Interim Report May – October 2011
November 1, 2011 New share issue Prospectus 2010-11-01
September 8, 2011 Interim Report May – July 2011
August 25, 2011 Annual Report 2010 / 2011
June 10, 2011 Year-end Report May 2010 – April 2011
March 9, 2011 Interim Report May 2010 – January 2011
December 9, 2010 Interim Report May-October 2010
September 9, 2010 Interim Report May – July 2010
August 26, 2010 Annual Report 2009 / 2010
June 10, 2010 Year-end Report May 2009 – April 2010
June 6, 2010 Listing Prospectus OMX 2010-06-17
February 26, 2010 Interim Report May 2009 – January 2010
December 10, 2009 Interim Report May 2009-October 2009
September 17, 2009 Oasmia Listing Prospectus 2007-09-17
September 10, 2009 Interim report May 2009 – July 2009
August 28, 2009 Annual Report 2008 / 2009
March 19, 2009 Interim report May 2008 – January 2009
December 10, 2008 Interim Report May 2008 – October 2008
September 16, 2008 Interim Report May – July 2008
August 29, 2008 Annual Report 2007 / 2008
June 16, 2008 Year-end Report 2007-05-01 – 2008-04-30
March 14, 2008 Interim Report May 2007 – January 2008
December 14, 2007 Interim Report May – October 2007
September 10, 2007 Communiqué from Annual General Meeting 2007-09-10
June 15, 2007 Year-end Report 2006-05-01 – 2007-04-30
December 10, 2006 Interim Report May – October 2006
August 14, 2006 Annual Report 2005 / 2006
September 27, 2005 Annual Report 2004 / 2005